Disease & disorder

platelet-type bleeding disorder 15

MONDO:0014078

Any inherited bleeding disorder, platelet-type in which the cause of the disease is a mutation in the ACTN1 gene, characterized by mild thrombocytopenia, enlarged platelets, and platelet anisocytosis, with most individuals exhibiting no bleeding or only mild epistaxis. Human platelet studies show normal aggregation, clot retraction, and spreading, indicating that bleeding symptoms arise from reduced platelet mass rather than functional defects. Missense variants in ACTN1 disrupt actin-filament organization in megakaryocytes, producing fewer and larger proplatelet tips and resulting in macrothrombocytopenia.

Clinical trials0
Recruiting0
Drug concepts studied0
Synonyms5

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

platelet-type bleeding disorder 15

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Drugs being studied

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.